Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation.

Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation. Nat Biotechnol. 2015 Aug; 33(8):845-852.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.